Kura Oncology KURA Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's accrued expenses?
- Kura Oncology (KURA) reported accrued expenses of $45.47M in Q1 2026.
- What is the long-term trend for Kura Oncology's accrued expenses?
- Over 2 years (2021 to 2025), Kura Oncology's accrued expenses has grown at a 90.8% compound annual growth rate (CAGR), from $16.96M to $61.7M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.